Fierce Pharma Asia—China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M series A December 10, 2021 Auto Bot News 0 Fierce Pharma Asia—China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M series A aliu Fri, 12/10/2021 – 02:51
